Capital One Financial Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $17
Capital One Financial analyst Naureen Quibria maintains $Fennec Pharmaceuticals(FENC.US)$ with a buy rating, and maintains the target price at $17.According to TipRanks data, the analyst has a success
Fennec Pharmaceuticals(FENC.US) Officer Sells US$16,433.56 in Common Stock
$Fennec Pharmaceuticals(FENC.US)$ Officer Raykov Rosty sold 2,431 shares of common stock on Jun 3, 2024 at an average price of $6.76 for a total value of $16,433.56.Source: Announcement What is statem
Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) 26% Dip In Price Shows Sentiment Is Matching Revenues
The Fennec Pharmaceuticals Inc. (NASDAQ:FENC) share price has fared very poorly over the last month, falling by a substantial 26%. Longer-term shareholders would now have taken a real hit with the
Is Fennec Pharmaceuticals (NASDAQ:FENC) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum
Express News | Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17
Fennec Pharmaceuticals: Temporary Setbacks With Strong Long-Term Outlook
Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Fennec Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 90.11% HC Wainwright & Co. $18 → $15 Maintains Buy 04/04/2024 128.14% HC Wainwright & Co. $17 →
Express News | Fennec Pharmaceuticals, Inc. : Craig-Hallum Cuts Target Price to $17 From $20
Maintained Buy Rating for Fennec Pharmaceuticals Amidst Revenue Growth and Strategic Partnerships
Express News | Fennec Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $15 From $18
Fennec Pharmaceuticals | 10-Q: Quarterly report
JAN, MTC and PROK Among Mid-day Movers
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Alibaba Group Holding Limited (NYSE:BABA) fell sharply during Tuesday's session following mixed first-quarter financial results.The e-commerce giant reported fiscal fourth-quarter 2023 reven
Express News | Fennec Pharmaceuticals Shares Are Trading Lower. The Company Reported Q1 Financial Results
Fennec Pharmaceuticals Inc. (FENC) Q1 2024 Earnings Call Transcript
Fennec Pharmaceuticals Inc. (FENC) Q1 2024 Earnings Call Transcript
Canada Net Change Percentage Gainers & Losers
GAINERS COMPANY SYMBOL LAST CHANGE PERCENT VOLUME ------- ------ ---- ------ ------- ------ Scandium I
Cutera, Inotiv, Treace Medical Concepts Among Healthcare Movers
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and BioLife Solutions (BLFS)
No Data